Hamzei Analytics Financial Network

Our mission is to provide valuable trading insights to advanced traders for analysis of mass behavior in the equity, bond, commodity and currency markets.

Showing posts with label Biotech. Show all posts

Monday, May 4, 2015

#IBB OTF Server Bias Update:

›

On Sunday (5-3-15) I posted/tweeted on @mocktrade that the OTF Server was confirming #IBB 350ish would be a potential resistance area ...

Thursday, April 30, 2015

#IBB OTF server bias update:

›

Our Prop OTF Server suggests until #IBB is first above 345.60 then above 352.55 bias remains bearish to 334/33 target then 329s ...

Wednesday, September 19, 2007

Pink slips at the FDA will equate to red ink for biotech investors

›

David Miller Andy von Eschenbach, FDA Commissioner, says he’ll have to issue 2,000 60-day pink slips at the FDA if Congress and the Presiden...

Saturday, April 21, 2007

Neurochem (NRMX)

›

David Miller Keep an eye out on Neurochem ( NRMX ) today. The option prices have been very high on this one because it has become yet anoth...

Tuesday, February 20, 2007

Margin Rules Might Make Development Stage Biotech Financials Matter

›

David Miller February 20, 2007 For development-stage biotechnology companies, quarter-to-quarter revenues don’t matter much because these f...

Wednesday, February 7, 2007

BioMarin Pharmaceuticals (BMRN)

›

David Miller February 7, 2007 At the end of this month, BioMarin Pharmaceuticals (BMRN) will report data from a pilot study on uncontrolled ...

›

Home

View web version